Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
9,917 results
- OASIS-HAE: A Study to Evaluate the Safety and Efficacy of Donidalorsen (ISIS 721744 or IONIS-PKK-LRx) in Participants With Hereditary Angioedema (HAE): Complete Statistical AnalysisIndependent statistical analysis of OASIS-HAE: A Study to Evaluate the Safety and Efficacy of Donidalorsen (ISIS 721744 or IONIS-PKK-LRx) in Participants With Hereditary Angioedema (HAE): primary endpoint results, effect estimate with confidence…
- OASIS(CM)Independent statistical analysis of Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- OATIndependent statistical analysis of Oral Anticoagulation Therapy Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01959425).
- Obatoclax for Systemic Mastocytosis: Complete Statistical AnalysisIndependent statistical analysis of Obatoclax for Systemic Mastocytosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00918931).
- ObePso-SIndependent statistical analysis of Study to Explore the Effect of Secukinumab, Compared to Placebo, on Fat Tissue and Skin in Plaque Psoriasis Patients: primary endpoint results, effect estimate with confidence interval, sample-size…
- Obesity and Nonalcoholic Fatty Liver Disease: Complete Statistical AnalysisIndependent statistical analysis of Obesity and Nonalcoholic Fatty Liver Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00262964).
- Obesity, Sleep Apnea, and Insulin Resistance: Complete Statistical AnalysisIndependent statistical analysis of Obesity, Sleep Apnea, and Insulin Resistance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02192684).
- Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma: Complete Statistical AnalysisIndependent statistical analysis of Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Observational Examination of Thermoregulation in Total Joint Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Observational Examination of Thermoregulation in Total Joint Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02225743).
- Observational Post-marketing Study on the Safety and Efficacy of Dotarem® (SECURE Study): Complete Statistical AnalysisIndependent statistical analysis of Observational Post-marketing Study on the Safety and Efficacy of Dotarem® (SECURE Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Observational Study of Deferiprone (Ferriprox®) in the Treatment of Superficial Siderosis: Complete Statistical AnalysisIndependent statistical analysis of Observational Study of Deferiprone (Ferriprox®) in the Treatment of Superficial Siderosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Observational Study of Nevirapine Extended Release in Human Immunodeficiency Virus (HIV) Patients in Daily Clinical Practice: Complete Statistical AnalysisIndependent statistical analysis of Observational Study of Nevirapine Extended Release in Human Immunodeficiency Virus (HIV) Patients in Daily Clinical Practice: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Observational Study on Hypothyroidism in Young Children Following Iodine Contrast Exposure: Complete Statistical AnalysisIndependent statistical analysis of Observational Study on Hypothyroidism in Young Children Following Iodine Contrast Exposure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Observational Study to Assess the Frequency of Lidocaine Ineffectiveness in Hard-to-treat ADHD: Complete Statistical AnalysisIndependent statistical analysis of Observational Study to Assess the Frequency of Lidocaine Ineffectiveness in Hard-to-treat ADHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Observational Study to Investigate the Long-term Effects of MIRCERA in Clinical Routine: Complete Statistical AnalysisIndependent statistical analysis of Observational Study to Investigate the Long-term Effects of MIRCERA in Clinical Routine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Observational Trial With Enbrel: Complete Statistical AnalysisIndependent statistical analysis of Observational Trial With Enbrel: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00488475).
- Observe the Effects of the Serkel Cranial Remolding Orthosis on Infants With Deformational Plagiocephaly: Complete Statistical AnalysisIndependent statistical analysis of Observe the Effects of the Serkel Cranial Remolding Orthosis on Infants With Deformational Plagiocephaly: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Obstructive Sleep Apnea in World Trade Center Responders: Complete Statistical AnalysisIndependent statistical analysis of Obstructive Sleep Apnea in World Trade Center Responders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01753999).
- Occurrence of Potential Bacterial and Viral Pathogens in Stable Chronic Obstructive Pulmonary Disease and During Acute Exacerbations of the Disease, in Asia Pacific: Complete Statistical AnalysisIndependent statistical analysis of Occurrence of Potential Bacterial and Viral Pathogens in Stable Chronic Obstructive Pulmonary Disease and During Acute Exacerbations of the Disease, in Asia Pacific: primary endpoint results, effect estimate…
- OCEANIndependent statistical analysis of Randomized Study of Obicetrapib in Combination With Ezetimibe: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04770389).
- OCT Pilot in Esophagus: Complete Statistical AnalysisIndependent statistical analysis of OCT Pilot in Esophagus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03434834).
- Ocular Comfort and OCT Observation of Post Lens Clearance and Ocular Tissue Compression: Complete Statistical AnalysisIndependent statistical analysis of Ocular Comfort and OCT Observation of Post Lens Clearance and Ocular Tissue Compression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Ocular Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration: Complete Statistical AnalysisIndependent statistical analysis of Ocular Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ODENIndependent statistical analysis of ODEN Trial: Option vs. Denali IVC Filters: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02201277).
- ODYSSEY FH IIIndependent statistical analysis of Study of Alirocumab (REGN727/SAR236553) in Patients With heFH (Heterozygous Familial Hypercholesterolemia) Who Are Not Adequately Controlled With Their LMT (Lipid-Modifying Therapy): primary endpoint results, effect estimate with confidence…
- ODYSSEY HoFHIndependent statistical analysis of Study in Participants With Homozygous Familial Hypercholesterolemia (HoFH): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03156621).
- ODYSSEY OUTCOMESComplete statistical analysis of ODYSSEY OUTCOMES, the randomized phase 3 trial of alirocumab versus placebo after acute coronary syndrome, including time-to-event endpoints, hazard ratios, stratified log-rank testing, multiplicity, safety, and statistical interpretation.
- Ofatumumab and Bendamustine Followed by Maintenance Ofatumumab for Rituximab Relapsed Indolent B-cell Non-Hodgkin’s Lymphoma (B-NHL): Complete Statistical AnalysisIndependent statistical analysis of Ofatumumab and Bendamustine Followed by Maintenance Ofatumumab for Rituximab Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Ofatumumab and Dinaciclib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Ofatumumab and Dinaciclib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia: primary endpoint results, effect estimate with confidence interval,…
- Ofatumumab and Fresh Frozen Plasma in Patients With Chronic Lymphocytic Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Ofatumumab and Fresh Frozen Plasma in Patients With Chronic Lymphocytic Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Ofatumumab for Minimal Residual Disease (MRD) and Maintenance Therapy: Complete Statistical AnalysisIndependent statistical analysis of Ofatumumab for Minimal Residual Disease (MRD) and Maintenance Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01258933).
- Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL): Complete Statistical AnalysisIndependent statistical analysis of Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Ofatumumab With High Dose Methylprednisone Followed by Ofatumumab and Alemtuzumab in 17p CLL: Complete Statistical AnalysisIndependent statistical analysis of Ofatumumab With High Dose Methylprednisone Followed by Ofatumumab and Alemtuzumab in 17p CLL: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- OHTSIndependent statistical analysis of Ocular Hypertension Treatment Study (OHTS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00000125).
- OIIndependent statistical analysis of Multicenter,Single-arm Study to Evaluate Efficacy, Safety, & Pharmacokinetics of Denosumab in Children w/ OI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- OKQ2Independent statistical analysis of One Key Question: Pilot Study at NorthShore: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03947788).
- OLAIndependent statistical analysis of Oligonucleotide Ligation Assay (OLA) Resistance Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01898754).
- Olanzapine for Prevention of Chemotherapy-induced Nausea and Vomiting in Children: A Multi-Centre Feasibility Study: Complete Statistical AnalysisIndependent statistical analysis of Olanzapine for Prevention of Chemotherapy-induced Nausea and Vomiting in Children: A Multi-Centre Feasibility Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Olaparib Before Surgery in Treating Participants With Localized Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Olaparib Before Surgery in Treating Participants With Localized Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03570476).
- Olaparib in Adults With Recurrent/Metastatic Ewing’s Sarcoma: Complete Statistical AnalysisIndependent statistical analysis of Olaparib in Adults With Recurrent/Metastatic Ewing's Sarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01583543).
- OLAPCOIndependent statistical analysis of OLAParib COmbinations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02576444).
- OLEIndependent statistical analysis of Open-label Extension Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- OLE-IEDATIndependent statistical analysis of Extension Treatment Using EryDex System in Patients With AT Who Participated in the ATTeST-IEDAT-02-2015 Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- OLE2Independent statistical analysis of An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Oleogel-S10 in Wound Healing of Inherited Epidermolysis Bullosa (BEB-10): Complete Statistical AnalysisIndependent statistical analysis of Oleogel-S10 in Wound Healing of Inherited Epidermolysis Bullosa (BEB-10): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01294241).
- OLFUS-VIPESIndependent statistical analysis of Follow-up of the VIPES Study to Evaluate Efficacy and Safety of Viaskin Peanut in Adults and Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- OLIFIndependent statistical analysis of OptiMesh® for Lumbar Interbody Fusion Trial (OLIF): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00764491).
- Olmesartan Comparison to Losartan in Hypertensive Subjects: Complete Statistical AnalysisIndependent statistical analysis of Olmesartan Comparison to Losartan in Hypertensive Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00949884).
- Olmesartan/HCTZ 40/12.5 mg Combination Therapy Versus Olmesartan Medoxomil 40 mg Monotherapy in Essential Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Olmesartan/HCTZ 40/12.5 mg Combination Therapy Versus Olmesartan Medoxomil 40 mg Monotherapy in Essential Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- OLOLIndependent statistical analysis of Our Lifestyles Our Lives: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02965729).